The risk of malignancy index in discrimination of adnexal masses

International Journal of Gynecology and Obstetrics

Volumn 96, Issue 3, 2007, Pages 186-191

  Ulusoy, S ^a   Akbayir, O ^a   Numanoglu, C ^a   Ulusoy, N ^a   Odabas, E ^a   Gulkilik, A ^a  

^a Istanbul Bakirkoy Women's and Children's Hospital   (Turkey)

Author keywords

Menopausal state; Ovarian cancer; ; Risk of malignancy index; ; Serum CA125 level; ; Ultrasound score;

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; BRENNER TUMOR; CANCER DIAGNOSIS; CANCER RISK; CLEAR CELL CARCINOMA; CYSTADENOCARCINOMA; DYSGERMINOMA; ENDOMETRIOID CARCINOMA; FEMALE; GRANULOSA CELL TUMOR; HUMAN; MENOPAUSE; OVARY CANCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TERATOMA; YOLK SAC TUMOR;

EID: 33847155136     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2006.10.006     Document Type: Article

References (17)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics, 2001. CA Cancer J Clin 51 (2001) 15-36
2. Landis S.H., Murray T., Bolden S., and Wingo P.A. Cancer statistics, 1998. CA Cancer J Clin 48 (1998) 6-29
3. Goldstein S.R. Postmenopausal adnexal cysts: how clinical management has evolved. Am J Obstet Gynecol 175 (1996) 1498-1501
4. Bell R., Petticrew M., and Sheldon T. The performance of screening tests for ovarian cancer: results of a systematic review. Br J Obstet Gynaecol 105 (1998) 1136-1147
5. Grimes D.A., and Hughes J.M. Use of multiphasic oral contraceptives and hospitalizations of women with functional ovarian cysts in the United States. Obstet Gynecol 73 (1989) 1037-1042
6. Jacobs I., Oram D., Fairbanks J., Turner J., Frost C., and Grudzinskas J.G. A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 97 10 (1990) 922-929
7. Serov S.F., Scully R.E., and Sobin L.H. International histological classification of tumors: No 9, histological typing of ovarian tumor (1973), World Health Organization, Geneva, Switzerland
8. Benedet J.L., Hacker N.F., and Ngan H.Y.S. Staging classifications and clinical practice guidelines of gynaecologic cancers. Int J Gynecol Obstet 70 (2000) 207-312
9. Davies A.P., Jacobs I.J., Woolas R., Fish A., and Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol 100 (1993) 927-931
10. Tingulstad S., Hagen B., Skjeldestad F.E., Onsrud M., Kiserud T., Halvorsen T., et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings, and menopausal status in the pre-operative diagnosis of adnexal masses. Br J Obstet Gynaecol 103 Suppl 8 (1996) 826-831
11. Ma S., Shen K., and Lang J. A risk of malignancy index in preoperative diagnosis of ovarian cancer. Chin Med J 116 Suppl 3 (2003) 396-399
12. Manjunath A.P., Sujatha K., and Vani R. Comparison of three risk of malignancy indices in evaluation of adnexal masses. Gynecol Oncol 81 (2001) 225-229
13. Tingulstad S., Hagen B., Skjeldestad F.E., Halvorsen T., Nustad K., and Onsrud M. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol 93 Suppl 3 (1999) 448-452
14. Torres J.C., Derchain S.F., Faundes A., Gontijo R.C., Martinez E.Z., and Andrade L.A. Risk of malignancy index in preoperative evaluation of clinically restricted ovarian cancer. Sao Paulo Med J/Rev Paul Med 120 Suppl 3 (2002) 72-76
15. Morgante G., la Marca A., Ditto A., and De Leo V. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses. Br J Obstet Gynaecol 106 (1999) 524-527
16. Andersen E.S., Knudsen A., Rix P., and Johansen B. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol 90 Suppl 1 (2003) 109-112
17. Obeidat B.R., Amarin Z.O., Latimer J.A., and Crawford R.A. Risk of malignancy index in the preoperative evaluation of adnexal masses. Int J Gynecol Obstet 85 Suppl 3 (2004) 255-258